The Elephant in the Room
Intellectual Asset Management Magazine
Publication Date: July 01, 2009
American corporate patent portfolios are in crisis. Applications have less than a 50% success rate, 25% yield patents valuable enough to keep, quality is low, most patents are marginally relevant, portfolios are bloated and costs are skyrocketing. Of course, no one is telling the CEO. Still, we should all be concerned. If getting patents were a product business, that business would be in serious trouble. It has a high product failure rate, and patent dollars are being squandered. Marginally relevant, and low-quality patents mean inadequate protection for corporate innovations. This at a time when patent rights are being eroded dramatically and when only the strongest patents will survive. There must be a better way.
Download the .PDF to learn more!